Abstract:BackgroundProtein disulfide isomerase A3 (PDIA3) is a member of the protein disulfide isomerase (PDI) family that participates in protein folding through its protein disulfide isomerase function. It has been reported to regulate the progression of several cancers, but its function in cancer immunotherapy is unknown. MethodsThe RNA-seq data of cancer and normal tissues were downloaded from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) databases. The Cbioportal dataset was used to explore the genomic alteration information of PDIA3 in pan-cancer. Human Protein Atlas (HPA) and ComPPI websites were employed to mine the protein information of PDIA3, and western blot assay was performed to monitor the upregulated PDIA3 expression in clinical GBM samples. The univariate Cox regression and the Kaplan-Meier method were utilized to appraise the prognostic role of PDIA3 in pan-cancer. Gene Set Enrichment Analysis (GSEA) was applied to search the associated cancer hallmarks with PDIA3 expression. TIMER2.0 was the main platform to investigate the immune cell infiltrations related to PDIA3 in pan-cancer. The associations between PDIA3 and immunotherapy biomarkers were performed by Spearman correlation analysis. The immunoblot was used to quantify the PDIA3 expression levels, and the proliferative and invasive ability of glioma cells was determined by colony formation and transwell assays. FindingsPDIA3 is overexpressed in most cancer types and exhibits prognosis predictive ability in various cancers, and it is especially expressed in the malignant cells and monocytes/macrophages. In addition, PDIA3 is significantly correlated with immune-activated hallmarks, cancer immune cell infiltrations, and immunoregulators, and the most interesting finding is that PDIA3 could significantly predict anti-PDL1 therapy response. Besides, specific inhibitors that correlated with PDIA3 expression in different cancer types were also screened by using Connectivity Map (CMap). Finally, knockdown of PDIA3 significantly weakened the proliferative and invasive ability of glioma cells. InterpretationThe results revealed that PDIA3 acts as a robust tumor biomarker. Its function in protein disulfide linkage regulation could influence protein synthesis, degradation, and secretion, and then shapes the tumor microenvironment, which might be further applied to develop novel anticancer inhibitors.

Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy

PDIA4 promotes glioblastoma progression via the PI3K/AKT/m-TOR pathway

Lin-28 Homolog B-Activated Protein Disulfide Isomerase A4 Regulates Cell Proliferation, Migration and Invasion of Glioma

P4HB and PDIA3 Are Associated with Tumor Progression and Therapeutic Outcome of Diffuse Gliomas

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma.

Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?

Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma

Protein Disulfide-Isomerase A3 is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively

Eukaryotic initiation factor 4 A-3 promotes glioblastoma growth and invasion through the Notch1-dependent pathway

Protein Disulfide Isomerase A2 is Correlated with Immune Infiltrates and is a Novel Prognostic Biomarker in Glioma Patients.

Role Of Aquaporin-4 In The Regulation Of Migration And Invasion Of Human Glioma Cells

High Expression of PDIA4 Promotes Malignant Cell Behavior and Predicts Reduced Survival in Cervical Cancer.

CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma

RUNX1-PDIA5 Axis Promotes Malignant Progression of Glioblastoma by Regulating CCAR1 Protein Expression

Protein Disulfide Isomerases Are Promising Targets for Predicting the Survival and Tumor Progression in Glioma Patients

ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade

Knockdown a Water Channel Protein, Aquaporin-4, Induced Glioblastoma Cell Apoptosis.

PDIA5 is Correlated with Immune Infiltration and Predicts Poor Prognosis in Gliomas

Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway

The role of SPI1/VSIG4/THBS1 on glioblastoma progression through modulation of the PI3K/AKT pathway

PDIA3 correlates with clinical malignant features and immune signature in human gliomas